Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Work
Year: 2007
Type: article
Abstract: Since sunitinib malate has shown activity in two uncontrolled studies in patients with metastatic renal-cell carcinoma, a comparison of the drug with interferon alfa in a phase 3 trial is warranted.We... more
Source: New England Journal of Medicine
Authors Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski +9 more
Institutions Memorial Sloan Kettering Cancer Center, Texas Oncology, Centrum Onkologii, Massachusetts General Hospital, Cleveland Clinic +8 more
Cites: 43
Cited by: 5,596
Related to: 10
FWCI: 410
Citation percentile (by year/subfield): 100
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze